Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine XR versus escitalopram effects on HPA-axis activity in unipolar depression
2009-011911-19Phase 3Active
- Sponsor
- Ludwig Maximilian University of Munich
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of quetiapine and escitalopram in major depressive disorder (MDD) (2 arms), sponsored by Ludwig Maximilian University of Munich. Primary endpoint: Total cortisol AUC during combined dexamethasone/CRH test. Started Apr 2009; status: active.
02
Drugs
quetiapineescitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2009-011911-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011911-19.